Hydrafacial Results Presentation Deck
Q3 2022 balance sheet highlights
Cash and Cash
Equivalents
Warrants
Convertible
Debt
Revolving Credit
Facility
Shares
Outstanding
31
1. As of 09/30/22.
Approximately $684.2 million cash and cash equivalents on balance sheet
Approximately 7.0 million Private Warrants outstanding¹
$750.0 million 1.25% convertible notes due 2026
Use of proceeds: capped call transaction, potential future acquisitions, working capital expenditures, and
general corporate purposes
Conversion price of $31.76; capped call agreement provides dilution protection up to $47.94
$50.0 million Senior Secured Credit Facility remains undrawn; current undrawn commitment fee of 25 bps
Allows flexibility for future M&A; ex-US operations unencumbered; convertible debt excluded from
covenants
✦ Approximately 143.2 million current shares outstanding¹
$100 million Accelerated Share Repurchase program expected to be completed by the end of Q1 2023
Additional $100 million share buyback authorization remaining
BEAUTYHEALTH™View entire presentation